Interviews

Interview—Peter Karli head of Heal Partners, Budapest, Hungary

Peter Karli, the urbane owner and MD of Central and Eastern European-focussed M&A advisory firm Heal Partners KFT, expects “explosive growth in Hungary’s dynamic for-profit healthcare market". HBI chats to him to find out more.

Interview: Peter Fish, CEO, Mendelian

HBI chats with Peter Fish, CEO of Mendelian, a company which combines patient medical records with the most-up-to date academic data on risk factors, using big data to uncover the patterns that doctors are missing and find the undiagnosed sufferers of rare diseases.

Interview: Arjan Toor, CEO, Cigna Europe

HBI chats with Arjan Toor, CEO of Cigna Europe, about innovation in the insurance market against a backdrop of the pandemic, and a growing crisis in mental health.

Interview: Chad Walkaden, OnTracka

HBI speaks to Chad Walkaden, the founder of OnTracka, a multipronged digital platform which can run decentralised clinical trials, collect real-world data from patients, and provide patients with a digital service which helps them to get the most out of their medicinal treatments.

Interview with Kate Newhouse, COO and Executive Director of Kooth

HBI caught up with Kate Newhouse, COO and executive director of digital mental health care group Kooth, before her appearance on the mental health panel at HBI2022. 

Interview: Christina Triantafyllou, head of improving patient experience, Siemens Healthineers

As patients are becoming increasingly savvy and well-informed healthcare consumers, the focus on patient experience has never been stronger, and the ongoing pandemic put this into even sharper focus. HBI catches up with Dr Christina Triantafyllou, Siemens Healthineers’ head of improving patient experience, to find out more.

New report: International Investing in Healthcare and Life Sciences 2022

The latest report from global law firm McDermott Will & Emery (McDermott) looks at the international investment landscape in healthcare, and life sciences. HBI speaks to McDermott’s London head of healthcare, Sharon Lamb to find out more.

Interview, Kirsty Bashforth, Chief business officer, Diaverum

Chronic Kidney Disease is a continuing to rise, further impacted by COVID and the wider economic burden. We discuss how digitalisation, improving health literacy and a more holistic approach could make a difference to the outlook in this sector with Kirsty Bashforth, chief business officer, Diaverum, ahead of her How to Build a Brand workshop at HBI 2022. 

Interview: Ulla Näpänkangas, CEO, Coronaria Eye Health Finland

HBI catches up with Ulla Näpänkangas, CEO at Finland's Coronaria Eye Health ahead of her appearance at HBI 2022 and hears how innovation in ophthalmology is as much about patient pathways and business models as it is about the tech.

Interview Nick West, Chief Medical Officer, Global Medical Affairs, Abbott Vascular 

Patients, particularly in Europe, the Middle East and Africa, have a very different view of how well their treatment went than the physicians who treat them and health care leaders who oversee healthcare delivery. Patients are frustrated from the earliest stages of their care journey, including symptom recognition and definitive disease diagnosis. We talk to Dr. Nick West, the Chief Medical Officer, Global Medical Affairs for Abbott’s Vascular business about the results from Beyond Intervention - a multi-year global research initiative that uncovers the differing perspectives of the patient, the physician, and the healthcare leader.

Find Us